본문 바로가기
KERD
논문KCI 등재

Immune Cell Responses and Mucosal Barrier Disruptions in Chronic Rhinosinusitis

1

조회

0

다운로드

9

인용

0

참고문헌

키워드

초록

Chronic rhinosinusitis (CRS) is one of the most common presentations of upper airway illness and severely affects patient quality of life. Its frequency is not surprising given levels of environmental exposure to microbes, pollutants, and allergens. Inflammatory cells, inflammatory cytokine and chemokine production, and airway remodeling have been detected in the sinonasal mucosae of CRS patients, although the precise pathophysiological mechanisms causing such persistent inflammation remain unclear. Given its high prevalence and considerable associated morbidity, continued research into CRS is necessary to increase our understanding of factors likely to contribute to its pathogenesis, and facilitate the development of novel therapeutic strategies to improve treatment. The purpose of this review is to summarize the current state of knowledge regarding immune cell responses and epithelial alterations in CRS.

Abstract

Chronic rhinosinusitis (CRS) is one of the most common presentations of upper airway illness and severely affects patient quality of life. Its frequency is not surprising given levels of environmental exposure to microbes, pollutants, and allergens. Inflammatory cells, inflammatory cytokine and chemokine production, and airway remodeling have been detected in the sinonasal mucosae of CRS patients, although the precise pathophysiological mechanisms causing such persistent inflammation remain unclear. Given its high prevalence and considerable associated morbidity, continued research into CRS is necessary to increase our understanding of factors likely to contribute to its pathogenesis, and facilitate the development of novel therapeutic strategies to improve treatment. The purpose of this review is to summarize the current state of knowledge regarding immune cell responses and epithelial alterations in CRS.

참고문헌 (65)

  1. Hamilos, D. L., "Chronic rhinosinusitis: epidemiology and medical management", J. Allergy Clin. Immunol, 128, pp.693~707 (2011)
  2. Soler, Z. M., "Chronic rhinosinusitis, race, and ethnicity", Am. J. Rhinol. Allergy, 26, pp.110~116 (2012)
  3. Stevens, W. W., "Chronic rhinosinusitis pathogenesis", J. Allergy Clin. Immunol, 136, pp.1442~1453 (2015)
  4. Kern, R. C., "Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis", Am. J. Rhinol, 22, pp.549~559 (2008)
  5. Payne, S. C., "Genetics and phenotyping in chronic sinusitis", J. Allergy Clin. Immunol, 128, pp.710~720 (2011)
  6. Cao, P. P., "Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese", J. Allergy Clin. Immunol, 124, pp.478~484 (2009)
  7. Kim, J. W., "Histological and immunological features of non-eosinophilic nasal polyps", Otolaryngol. Head Neck Surg, 137, pp.925~930 (2007)
  8. Ikeda, K., "Subclassification of chronic rhinosinusitis with nasal polyp based on eosinophil and neutrophil", Laryngoscope, 123, pp.E1~E9 (2013)
  9. Wen, W., "Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy", J. Allergy Clin. Immunol, 129, pp.1522~1528 (2012)
  10. Kim, S. J., "Changes in histological features of nasal polyps in a Korean population over a 17-year period. Otolaryngol", Head Neck Surg, 149, pp.431~437 (2013)
  11. Van, Z. T., "Differentiation of chronic sinus diseases by measurement of inflammatory mediators", Allergy, 61, pp.1280~1289 (2006)
  12. Van, B. N., "T-cell regulation in chronic paranasal sinus disease", J. Allergy Clin. Immunol, 121, pp.1435~1441 (2008)
  13. Park, S. J., "Chronic rhinosinusitis with polyps and without polyps is associated with increased expression of suppressors of cytokine signaling 1 and 3", J. Allergy Clin. Immunol, 131, pp.772~780 (2013)
  14. Nagarkar, D. R., "Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis", J. Allergy Clin. Immunol, 132, pp.593~600 (2013)
  15. Zhang, N., "Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease", J. Allergy Clin. Immunol, 122, pp.961~968 (2008)
  16. Van, B. N., "TGF-beta signaling and collagen deposition in chronic rhinosinusitis", J. Allergy Clin. Immunol, 124, pp.253~259 (2009)
  17. Sejima, T., "Cytokine profiles in Japanese patients with chronic rhinosinusitis", Allergol. Int, 61, pp.115~122 (2012)
  18. Shi, L. L., "Features of airway remodeling in different types of Chinese chronic rhinosinusitis are associated with inflammation patterns", Allergy, 68, pp.101~109 (2013)
  19. Van, B. N., "Inflammation and remodelling patterns in early stage chronic rhinosinusitis", Clin. Exp. Allergy, 42, pp.883~890 (2012)
  20. Bachert, C., "Important research questions in allergy and related diseases : 3-chronic rhinosinusitis and nasal polyposis-a GALEN study", Allergy, 64, pp.520~533 (2009)
  21. Polzehl, D., "Distinct features of chronic rhinosinusitis with and without nasal polyps", Allergy, 61, pp.1275~1279 (2006)
  22. Kato, A., "Immunopathology of chronic rhinosinusitis", Allergol. Int, 64, pp.121~130 (2015)
  23. Katotomichelakis, M., "Inflammatory patterns in upper airway disease in the same geographical area may change over time", Am. J. Rhinol. Allergy, 27, pp.354~360 (2013)
  24. Bruce S Bochner, "Eosinophil Survival and Apoptosis in Health and Disease", Allergy, Asthma & Immunology Research, 2(2), pp.87~101 (2010), 대한천식알레르기학회
  25. Kouro, T., "IL-5- and eosinophilmediated inflammation: from discovery to therapy", Int. Immunol, 21, pp.1303~1309 (2009)
  26. Bachert, C., "IL-5 synthesis is upregulated in human nasal polyp tissue", J. Allergy Clin. Immunol, 99, pp.837~842 (1997)
  27. Mackay, C. R., "Chemokines: immunology's high impact factors", Nat. Immunol, 2, pp.95~101 (2001)
  28. Yao, T., "Eotaxin-1, -2, and-3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients", Laryngoscope, 119, pp.1053~1059 (2009)
  29. Olze, H., "Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3", Rhinology, 44, pp.145~150 (2006)
  30. Early, S. B., "Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts", Laryngoscope, 117, pp.511~515 (2007)
  31. Nissim Ben Efraim, A. H., "Hypoxia modulates human eosinophil function", Clin. Mol. Allergy, 8, pp.10~ (2010)
  32. Takabayashi, T., "Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps", J. Allergy Clin. Immunol, 130, pp.410~420 (2012)
  33. Cao, P. P., "Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps", Clin. Exp. Allergy, 44, pp.690~700 (2014)
  34. Mahdavinia, M., "Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity", J. Allergy Clin. Immunol, 133, pp.1759~1763 (2014)
  35. Soyka, M. B., "Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4", J. Allergy Clin. Immunol, 130, pp.1087~1096 (2012)
  36. Nomura, K., "Pseudomonas aeruginosa elastase causes transient disruption of tight junctions and downregulation of PAR-2 in human nasal epithelial cells", Respir. Res, 15, pp.21~ (2014)
  37. Shin, H. W., "Hypoxia-inducible factor 1 mediates nasal polypogenesis by inducing epithelial-to-mesenchymal transition", Am. J. Respir. Crit Care Med, 185, pp.944~954 (2012)
  38. Hupin, C., "Features of mesenchymal transition in the airway epithelium from chronic rhinosinusitis", Allergy, 69, pp.1540~1549 (2014)
  39. Lee, M., "Sirtuin 1 attenuates nasal polypogenesis by suppressing epithelial-to-mesenchymal transition", J. Allergy Clin. Immunol, 137, pp.87~98 (2016)
  40. Lim, J. H., "Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha", Mol. Cell, 38, pp.864~878 (2010)
  41. Yoon, H., "Differential roles of Sirt1 in HIF-1alpha and HIF-2alpha mediated hypoxic responses", Biochem. Biophys. Res. Commun, 444, pp.36~43 (2014)
  42. Kim, S. W., "Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model", Allergy, 68, pp.862~869 (2013)
  43. Zhang, N., "Barrier function of the nasal mucosa in health and type-2biased airway diseases", Allergy, 71, pp.295~307 (2016)
  44. Esplugues, E., "Control of TH17 cells occurs in the small intestine", Nature, 475, pp.514~518 (2011)
  45. Ke, Y., "Anti-inflammatory role of IL-17 in experimental autoimmune uveitis", J. Immunol, 182, pp.3183~3190 (2009)
  46. Otani, K., "Anti-inflammatory effects of IL-17A on Helicobacter pylori-induced gastritis", Biochem. Biophys. Res. Commun, 382, pp.252~258 (2009)
  47. Pappu, R., "The interleukin-17 cytokine family : critical players in host defence and inflammatory diseases", Immunology, 134, pp.8~16 (2011)
  48. Zizzo, G., "IL-17 stimulates differentiation of human anti-inflammatory macrophages and phagocytosis of apoptotic neutrophils in response to IL-10 and glucocorticoids", J. Immunol, 190, pp.5237~5246 (2013)
  49. Lee, M., "Targeting IL-25as a novel therapy in chronic rhinosinusitis with nasal polyps", Curr. Opin. Allergy Clin. Immunol, 17, pp.17~22 (2017)
  50. Pappu, R., "Regulation of epithelial immunity by IL-17 family cytokines", Trends Immunol, 33, pp.343~349 (2012)
  51. Hurst, S. D., "New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25", J. Immunol, 169, pp.443~453 (2002)
  52. Fort, M. M., "IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo", Immunity, 15, pp.985~995 (2001)
  53. Ballantyne, S. J., "Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma", J. Allergy Clin. Immunol, 120, pp.1324~1331 (2007)
  54. Shin, H. W., "IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis", J. Allergy Clin. Immunol, 135, pp.1476~1485 (2015)
  55. Miljkovic, D., "Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis", Allergy, 69, pp.1154~1161 (2014)
  56. Mjosberg, J. M., "Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161", Nat. Immunol, 12, pp.1055~1062 (2011)
  57. Smith, D. E., "IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma", Clin. Exp. Allergy, 40, pp.200~208 (2010)
  58. Bulek, K., "Epithelium: the interplay between innate and Th2 immunity", Immunol. Cell Biol, 88, pp.257~268 (2010)
  59. Lam, M., "Clinical severity and epithelial endotypes in chronic rhinosinusitis", Int. Forum Allergy Rhinol, 3, pp.121~128 (2013)
  60. Dong-Kyu Kim, "The role of interleukin-33 in chronic rhinosinusitis", Thorax, 72(7), pp.635~645 (2017), BMJ[DOI]
  61. Allakhverdi, Z., "CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation", J. Allergy Clin. Immunol, 123, pp.472~478 (2009)
  62. Kim, D. W., "Prolonged allergen exposure is associated with increased thymic stromal lymphopoietin expression and Th2-skewing in mouse models of chronic rhinosinusitis", Laryngoscope, 126, pp.E265~E272 (2016)
  63. Kim, D. W., "Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model", Am. J. Rhinol. Allergy, 25, pp.e255~e261 (2011)
  64. Khalmuratova, R., "Induction of nasal polyps using house dust mite and Staphylococcal enterotoxin B in C57BL", 6 mice. Allergol, 2016, pp.44, 66~75
  65. Shin H. W., "Animal models in CRS and pathophysiologic insights gained: A systematic review", Laryngoscope Investig. Otolaryngol, 1, pp.116~123 (2016)

관련 논문AI추천

이 간행물의 다른 논문 (7건)